588 related articles for article (PubMed ID: 25727069)
1. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
[TBL] [Abstract][Full Text] [Related]
2. Foxp3+ regulatory T cells are activated in spite of B7-CD28 and CD40-CD40L blockade.
Vogel I; Verbinnen B; Maes W; Boon L; Van Gool SW; Ceuppens JL
Eur J Immunol; 2013 Apr; 43(4):1013-23. PubMed ID: 23348953
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis.
Perrin PJ; June CH; Maldonado JH; Ratts RB; Racke MK
J Immunol; 1999 Aug; 163(3):1704-10. PubMed ID: 10415078
[TBL] [Abstract][Full Text] [Related]
4. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
Perrin PJ; Maldonado JH; Davis TA; June CH; Racke MK
J Immunol; 1996 Aug; 157(4):1333-6. PubMed ID: 8759711
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
Quattrocchi E; Dallman MJ; Feldmann M
Arthritis Rheum; 2000 Aug; 43(8):1688-97. PubMed ID: 10943858
[TBL] [Abstract][Full Text] [Related]
7. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
[TBL] [Abstract][Full Text] [Related]
8. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
9. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
10. The effect of CTLA-4Ig, a CD28/B7 antagonist, on the lung inflammation and T cell subset profile during murine hypersensitivity pneumonitis.
Jiménez-Alvarez L; Arreola JL; Ramírez-Martínez G; Ortiz-Quintero B; Gaxiola M; Reynoso-Robles R; Avila-Moreno F; Urrea F; Pardo A; Selman M; Zuñiga J
Exp Mol Pathol; 2011 Dec; 91(3):718-22. PubMed ID: 21945736
[TBL] [Abstract][Full Text] [Related]
11. The role of costimulation in autoimmune demyelination.
Racke MK; Ratts RB; Arredondo L; Perrin PJ; Lovett-Racke A
J Neuroimmunol; 2000 Jul; 107(2):205-15. PubMed ID: 10854658
[TBL] [Abstract][Full Text] [Related]
12. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
13. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
[TBL] [Abstract][Full Text] [Related]
14. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
15. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
[TBL] [Abstract][Full Text] [Related]
16. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system.
Khoury SJ; Akalin E; Chandraker A; Turka LA; Linsley PS; Sayegh MH; Hancock WW
J Immunol; 1995 Nov; 155(10):4521-4. PubMed ID: 7594447
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
[TBL] [Abstract][Full Text] [Related]
18. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
20. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
